Literature DB >> 25856492

Cell-based screening: extracting meaning from complex data.

Steven Finkbeiner1, Michael Frumkin2, Paul D Kassner3.   

Abstract

Unbiased discovery approaches have the potential to uncover neurobiological insights into CNS disease and lead to the development of therapies. Here, we review lessons learned from imaging-based screening approaches and recent advances in these areas, including powerful new computational tools to synthesize complex data into more useful knowledge that can reliably guide future research and development.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25856492      PMCID: PMC4457442          DOI: 10.1016/j.neuron.2015.02.023

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  142 in total

1.  A photoconvertible reporter of the ubiquitin-proteasome system in vivo.

Authors:  Geert Hamer; Olli Matilainen; Carina I Holmberg
Journal:  Nat Methods       Date:  2010-05-09       Impact factor: 28.547

2.  High-throughput RNAi screening to dissect cellular pathways: a how-to guide.

Authors:  Christina Falschlehner; Sandra Steinbrink; Gerrit Erdmann; Michael Boutros
Journal:  Biotechnol J       Date:  2010-04       Impact factor: 4.677

3.  Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.

Authors:  Benjamin Berger; Anna Katharina Rothmaier; Franziska Wedekind; Josef Zentner; Thomas J Feuerstein; Rolf Jackisch
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 4.  FRET in cell biology: still shining in the age of super-resolution?

Authors:  Hernán E Grecco; Peter J Verveer
Journal:  Chemphyschem       Date:  2010-12-29       Impact factor: 3.102

5.  A whole-cell computational model predicts phenotype from genotype.

Authors:  Jonathan R Karr; Jayodita C Sanghvi; Derek N Macklin; Miriam V Gutschow; Jared M Jacobs; Benjamin Bolival; Nacyra Assad-Garcia; John I Glass; Markus W Covert
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

6.  Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.

Authors:  Ningzhe Zhang; Mahru C An; Daniel Montoro; Lisa M Ellerby
Journal:  PLoS Curr       Date:  2010-10-28

7.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

Review 8.  Designing materials to direct stem-cell fate.

Authors:  Matthias P Lutolf; Penney M Gilbert; Helen M Blau
Journal:  Nature       Date:  2009-11-26       Impact factor: 49.962

9.  Antilipolytic effects of alpha 2-adrenergic agonists, neuropeptide Y, adenosine, and PGE1 in mammal adipocytes.

Authors:  I Castan; P Valet; N Quideau; T Voisin; L Ambid; M Laburthe; M Lafontan; C Carpéné
Journal:  Am J Physiol       Date:  1994-04

10.  Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.

Authors:  Sami J Barmada; Andrea Serio; Arpana Arjun; Bilada Bilican; Aaron Daub; D Michael Ando; Andrey Tsvetkov; Michael Pleiss; Xingli Li; Daniel Peisach; Christopher Shaw; Siddharthan Chandran; Steven Finkbeiner
Journal:  Nat Chem Biol       Date:  2014-06-29       Impact factor: 15.040

View more
  17 in total

1.  In Silico Labeling: Predicting Fluorescent Labels in Unlabeled Images.

Authors:  Eric M Christiansen; Samuel J Yang; D Michael Ando; Ashkan Javaherian; Gaia Skibinski; Scott Lipnick; Elliot Mount; Alison O'Neil; Kevan Shah; Alicia K Lee; Piyush Goyal; William Fedus; Ryan Poplin; Andre Esteva; Marc Berndl; Lee L Rubin; Philip Nelson; Steven Finkbeiner
Journal:  Cell       Date:  2018-04-12       Impact factor: 41.582

Review 2.  Cell death assays for neurodegenerative disease drug discovery.

Authors:  Jeremy W Linsley; Terry Reisine; Steven Finkbeiner
Journal:  Expert Opin Drug Discov       Date:  2019-06-10       Impact factor: 6.098

Review 3.  Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.

Authors:  Kelly M Haston; Steven Finkbeiner
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-28       Impact factor: 13.820

Review 4.  iPS cells in the study of PD molecular pathogenesis.

Authors:  Melanie M Cobb; Abinaya Ravisankar; Gaia Skibinski; Steven Finkbeiner
Journal:  Cell Tissue Res       Date:  2017-12-12       Impact factor: 5.249

Review 5.  The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders.

Authors:  A Jeremy Willsey; Montana T Morris; Sheng Wang; Helen R Willsey; Nawei Sun; Nia Teerikorpi; Tierney B Baum; Gerard Cagney; Kevin J Bender; Tejal A Desai; Deepak Srivastava; Graeme W Davis; Jennifer Doudna; Edward Chang; Vikaas Sohal; Daniel H Lowenstein; Hao Li; David Agard; Michael J Keiser; Brian Shoichet; Mark von Zastrow; Lennart Mucke; Steven Finkbeiner; Li Gan; Nenad Sestan; Michael E Ward; Ruth Huttenhain; Tomasz J Nowakowski; Hugo J Bellen; Loren M Frank; Mustafa K Khokha; Richard P Lifton; Martin Kampmann; Trey Ideker; Matthew W State; Nevan J Krogan
Journal:  Cell       Date:  2018-07-26       Impact factor: 41.582

6.  Rapid 3D phenotypic analysis of neurons and organoids using data-driven cell segmentation-free machine learning.

Authors:  Philipp Mergenthaler; Santosh Hariharan; James M Pemberton; Corey Lourenco; Linda Z Penn; David W Andrews
Journal:  PLoS Comput Biol       Date:  2021-02-22       Impact factor: 4.475

7.  Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia.

Authors:  Martin Tamtè; Ivani Brys; Ulrike Richter; Nedjeljka Ivica; Pär Halje; Per Petersson
Journal:  J Neurophysiol       Date:  2016-01-06       Impact factor: 2.714

Review 8.  Stem Cells, Genome Editing, and the Path to Translational Medicine.

Authors:  Frank Soldner; Rudolf Jaenisch
Journal:  Cell       Date:  2018-10-18       Impact factor: 41.582

Review 9.  Concise Review: Progress and Challenges in Using Human Stem Cells for Biological and Therapeutics Discovery: Neuropsychiatric Disorders.

Authors:  David M Panchision
Journal:  Stem Cells       Date:  2016-02-11       Impact factor: 6.277

Review 10.  Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.

Authors:  Stephen J Haggarty; M Catarina Silva; Alan Cross; Nicholas J Brandon; Roy H Perlis
Journal:  Mol Cell Neurosci       Date:  2016-01-28       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.